Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 5/20 | 0.50 |
| ▸ | CA2 | P00918 | 5/20 | 0.50 |
| ▸ | CA4 | P22748 | 5/20 | 0.50 |
| ▸ | CA9 | Q16790 | 5/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | DUT | P33316 | 7/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28803795 | 0.93 | ALDH1A1 (0.54) | ALDH1A1LMNAKDM4EMEN1KMT2A | |
| SCHEMBL28803862 | 0.92 | ALDH1A1 (0.52) | ALDH1A1LMNAKDM4EMEN1KMT2A | |
| SCHEMBL29167329 | 0.90 | ALDH1A1 (0.51) | ALDH1A1LMNAKDM4EMEN1KMT2A | |
| SCHEMBL11983580 | 0.83 | ALDH1A1 (0.58) | ALDH1A1LMNAKDM4EMEN1KMT2A | |
| SCHEMBL11710759 | 0.83 | ALDH1A1 (0.58) | ALDH1A1LMNAKDM4EMEN1KMT2A | |
| SCHEMBL11710750 | 0.83 | ALDH1A1 (0.58) | ALDH1A1LMNAKDM4EMEN1KMT2A | |
| SCHEMBL1673256 | 0.81 | KMT2A (0.42) | ALDH1A1LMNAKDM4EMEN1KMT2A | |
| SCHEMBL8135756 | 0.81 | DUT (0.58) | ALDH1A1LMNAL3MBTL1DUT | |
| SCHEMBL667245 | 0.80 | ALDH1A1 (0.59) | ALDH1A1LMNAKDM4EMEN1KMT2A | |
| SCHEMBL27703786 | 0.80 | ALDH1A1 (0.55) | ALDH1A1LMNAKDM4EMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 406 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114702514-B | Copper tetrafluoroborate complex of 2,2' -bipyridine and uracil-1-yl acetate, and preparation method and application thereof | 温州大学新材料与产业技术研究院 | 2024-01-02 | — | — | CN | claimed |
| CN-114702514-A | 2,2' -bipyridine and uracil-1-base acetic acid copper tetrafluoroborate complex and preparation method and application thereof | 温州大学新材料与产业技术研究院 | 2022-07-05 | — | — | CN | claimed |
| US-20190262794-A1 | SUBSTRATES, SYSTEMS, AND METHODS FOR NUCLEIC ACID ARRAY SYNTHESIS | VIBRANT HOLDINGS, LLC | 2019-08-29 | — | — | US | claimed |
| EP-3402897-A1 | SUBSTRATES, SYSTEMS, AND METHODS FOR NUCLEIC ACID ARRAY SYNTHESIS | Vibrant Holdings, LLC (US) | 2018-11-21 | — | — | EP | claimed |
| WO-2017117292-A1 | SUBSTRATES, SYSTEMS, AND METHODS FOR NUCLEIC ACID ARRAY SYNTHESIS | VIBRANT HOLDINGS, LLC (US) | 2017-07-06 | — | — | WO | claimed |
| EP-0792283-A1 | SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH | CHIRON CORPORATION (US) | 1997-09-03 | — | — | EP | claimed |
| WO-1996015143-A1 | SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH | CHIRON CORPORATION (US) | 1996-05-23 | — | — | WO | claimed |
| US-20260072035-A1 | ENHANCED SPECIFICITY MASS TAG DNA ADDUCTOMICS | UNIV NORTHEASTERN (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4620948-A1 | LIPID COMPOUND AND COMPOSITION FOR DELIVERY OF ACTIVE SUBSTANCE | Korea Research Institute of Bioscience and Biotechnology (KR) | 2025-09-24 | — | — | EP | disclosed |
| US-20250236612-A1 | RAPIDLY ACCELERATING FIBROSARCOMA PROTEIN DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE | ARVINAS OPERATIONS, INC. | 2025-07-24 | — | — | US | disclosed |
| WO-2025092267-A1 | NUCLEOSIDE AND NUCLEOTIDE ANALOG, DOUBLE-STRANDED OLIGONUCLEOTIDE AND CONJUGATE CONTAINING NUCLEOTIDE ANALOG, AND USE THEREOF | 北京炫景瑞医药科技有限公司 | 2025-05-08 | — | — | WO | disclosed |
| EP-4511513-A1 | ENHANCED SPECIFICITY MASS TAG DNA ADDUCTOMICS | Northeastern University (US) | 2025-02-26 | — | — | EP | disclosed |
| US-12180193-B2 | Accelerating fibrosarcoma protein degrading compounds and associated methods of use | ARVINAS OPERATIONS, INC. (US) | 2024-12-31 | — | — | US | disclosed |
| WO-1995019779-A1 | DELTEX PROTEINS, NUCLEIC ACIDS, AND ANTIBODIES, AND RELATED METHODS AND COMPOSITIONS | YALE UNIVERSITY (US) | 1995-07-27 | — | — | WO | disclosed |
| US-5213972-A | Production of thymidine and deoxyuridine, intermediates for AZT | CHEMGEN CORPORATION (US) | 1993-05-25 | — | — | US | disclosed |
| EP-0504279-A4 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES | — | 1993-02-17 | — | — | EP | disclosed |
| EP-0504279-A1 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES. | CHEMGEN CORP (US) | 1992-09-23 | — | — | EP | disclosed |
| WO-1991009130-A1 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES | CHEMGEN CORPORATION (US) | 1991-06-27 | — | — | WO | disclosed |
| US-4008221-A | BACTERICIDE, ANTIBIOTIC | RICHARDSON-MERRELL INC. (US) | 1977-02-15 | — | — | US | disclosed |
| US-3956288-A | 7-[(2,4-Dioxo-1-pyrimidinyl)acylamino]cephalosporin derivatives | RICHARDSON-MERRELL INC. (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12180193-B2 | Accelerating fibrosarcoma protein degrading compounds and associated methods of use | CRBN, RBX1, ARAF | ALDH1A1 2803/4885LMNA 2304/4885KDM4E 2141/4885 |
| US-20250236612-A1 | RAPIDLY ACCELERATING FIBROSARCOMA PROTEIN DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE | CRBN, RBX1, ARAF | ALDH1A1 2856/4885LMNA 2101/4885KDM4E 2141/4885 |
| US-20260072035-A1 | ENHANCED SPECIFICITY MASS TAG DNA ADDUCTOMICS | DNMT3A, APEX1, CHAMP1 | ALDH1A1 941/4885LMNA 664/4885KDM4E 1562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.